PG
GILD icon

PEAK6 Group’s Gilead Sciences GILD Stock Holding History

PEAK6 Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$9.17M Sell
129,400
-163,400
-56% -$11.5M 0.04% 474
2018
Q1 		$22.1M Buy
292,800
+78,700
+37% +$6.26M 0.1% 207
2017
Q4 		$15.3M Sell
214,100
-509,800
-70% -$38.7M 0.07% 307
2017
Q3 		$58.6M Buy
723,900
+404,500
+127% +$30.9M 0.3% 47
2017
Q2 		$22.6M Buy
319,400
+306,000
+2,284% +$20.4M 0.13% 131
2017
Q1 		$910K Sell
13,400
-361,300
-96% -$25.4M 0.01% 1763
2016
Q4 		$26.8M Buy
374,700
+223,000
+147% +$16.6M 0.19% 76
2016
Q3 		$12M Sell
151,700
-251,100
-62% -$20.4M 0.09% 279
2016
Q2 		$33.6M Sell
402,800
-418,800
-51% -$37.2M 0.26% 43
2016
Q1 		$75.5M Buy
821,600
+422,000
+106% +$38.1M 0.61% 3
2015
Q4 		$40.4M Sell
399,600
-68,300
-15% -$7.11M 0.27% 39
2015
Q3 		$45.9M Sell
467,900
-159,300
-25% -$17.7M 0.24% 51
2015
Q2 		$73.4M Buy
627,200
+533,700
+571% +$58.3M 0.44% 8
2015
Q1 		$9.18M Sell
93,500
-142,400
-60% -$14.5M 0.07% 364
2014
Q4 		$22.2M Sell
235,900
-23,900
-9% -$2.47M 0.17% 110
2014
Q3 		$27.7M Buy
259,800
+170,100
+190% +$16.7M 0.21% 70
2014
Q2 		$7.44M Buy
89,700
+41,400
+86% +$3.22M 0.07% 354
2014
Q1 		$3.42M Sell
48,300
-67,900
-58% -$5.33M 0.03% 874
2013
Q4 		$8.73M Sell
116,200
-384,600
-77% -$26.8M 0.06% 391
2013
Q3 		$15.8M Buy
500,800
+307,000
+158% +$18.3M 0.11% 172
2013
Q2 		$9.94K Buy
+193,800
New +$10.1M 0.04% 324

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PEAK6 Group's GILD Position: Q2 2018 in Review

PEAK6 Group increased its Gilead Sciences (GILD) stake by 29% in Q2 2018, buying an estimated $2.58M and bringing the position to 161,250 shares worth $11.4M. The position accounts for 0.05% of the portfolio, ranked #393.

PEAK6 Group first reported a position in GILD in Q2 2013 and has held it in 20 quarters since. The position peaked at $46.3M in Q1 2017. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • PEAK6 Group held 161,250 shares of Gilead Sciences worth $11.4M as of Q2 2018.
  • PEAK6 Group bought 36,534 Gilead Sciences shares in Q2 2018, an estimated $2.58M.
  • Gilead Sciences made up 0.05% of PEAK6 Group's portfolio in Q2 2018, its #393 holding.
  • PEAK6 Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 20 quarters since.
  • PEAK6 Group's Gilead Sciences position peaked at $46.3M in Q1 2017.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.